intranasal glutathione in parkinson& 39 S-transferase: A keystone Parkinson's disease pathogenesis and therapy Targets to Search for New
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single Neuron Degeneration Model Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties PMC Glutathionea review on its role and significance in Parkinson's disease Martin 2009 The FASEB Journal Wiley Online Library Frontiers Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives The irony of Parkinson's disease: Converging mechanisms of redox imbalance and ferroptosis ScienceDirect
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22




